Werewolf Therapeutics Inc Sustainability Reports
Werewolf Therapeutics, Inc. is a biopharmaceutical company that designs and develops conditionally activated immunotherapies for the treatment of cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00QXQ9XL3
1 reports from 2023 to 2023
Company Profile
Werewolf Therapeutics, Inc. is a biopharmaceutical company that designs and develops conditionally activated immunotherapies for the treatment of cancer.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years